The role of PET/CT in determining egfr mutation and ALK rearrangement in patients with lung adenocarcinoma . Ann Med Res [Internet]. 2021 May 25 [cited 2025 Apr. 5];27(2):0634-40. Available from: http://annalsmedres.org/index.php/aomr/article/view/607